Literature DB >> 23136038

Match criteria for human cell line authentication: where do we draw the line?

Amanda Capes-Davis1, Yvonne A Reid, Margaret C Kline, Douglas R Storts, Ethan Strauss, Wilhelm G Dirks, Hans G Drexler, Roderick A F MacLeod, Gregory Sykes, Arihiro Kohara, Yukio Nakamura, Eugene Elmore, Raymond W Nims, Christine Alston-Roberts, Rita Barallon, Georgyi V Los, Roland M Nardone, Paul J Price, Anton Steuer, Jim Thomson, John R W Masters, Liz Kerrigan.   

Abstract

Continuous human cell lines have been used extensively as models for biomedical research. In working with these cell lines, researchers are often unaware of the risk of cross-contamination and other causes of misidentification. To reduce this risk, there is a pressing need to authenticate cell lines, comparing the sample handled in the laboratory to a previously tested sample. The American Type Culture Collection Standards Development Organization Workgroup ASN-0002 has developed a Standard for human cell line authentication, recommending short tandem repeat (STR) profiling for authentication of human cell lines. However, there are known limitations to the technique when applied to cultured samples, including possible genetic drift with passage. In our study, a dataset of 2,279 STR profiles from four cell banks was used to assess the effectiveness of the match criteria recommended within the Standard. Of these 2,279 STR profiles, 1,157 were grouped into sets of related cell lines-duplicate holdings, legitimately related samples or misidentified cell lines. Eight core STR loci plus amelogenin were used to unequivocally authenticate 98% of these related sets. Two simple match algorithms each clearly discriminated between related and unrelated samples, with separation between related samples at ≥80% match and unrelated samples at <50% match. A small degree of overlap was noted at 50-79% match, mostly from cell lines known to display variable STR profiles. These match criteria are recommended as a simple and effective way to interpret results from STR profiling of human cell lines.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 23136038     DOI: 10.1002/ijc.27931

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  77 in total

1.  255-nm Light-emitting Diode Kills Enterococcus faecalis and Induces the Production of Cellular Biomarkers in Human Embryonic Palatal Mesenchyme Cells and Gingival Fibroblasts.

Authors:  Kimberly Morio; Emma L Thayer; Amber M Bates; Kim A Brogden
Journal:  J Endod       Date:  2019-03-29       Impact factor: 4.171

2.  Identity Crisis - Rigor and Reproducibility in Human Cell Lines.

Authors:  Jaimee C Eckers; Adam D Swick; Randall J Kimple
Journal:  Radiat Res       Date:  2018-04-13       Impact factor: 2.841

3.  A resource for cell line authentication, annotation and quality control.

Authors:  Mamie Yu; Suresh K Selvaraj; May M Y Liang-Chu; Sahar Aghajani; Matthew Busse; Jean Yuan; Genee Lee; Franklin Peale; Christiaan Klijn; Richard Bourgon; Joshua S Kaminker; Richard M Neve
Journal:  Nature       Date:  2015-04-16       Impact factor: 49.962

4.  Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS/AP-1 sites and in cell migration.

Authors:  Nagarathinam Selvaraj; Justin A Budka; Mary W Ferris; Joshua P Plotnik; Peter C Hollenhorst
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

5.  The Cellosaurus, a Cell-Line Knowledge Resource.

Authors:  Amos Bairoch
Journal:  J Biomol Tech       Date:  2018-05-10

6.  Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.

Authors:  Fusako Kito; Rieko Oyama; Marimu Sakumoto; Kumiko Shiozawa; Zhiwei Qiao; Shunichi Toki; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  Hum Cell       Date:  2019-02-08       Impact factor: 4.174

7.  PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.

Authors:  Wenli Cui; Shutao Zheng; Xinxia Li; Yuqing Ma; Wei Sang; Ming Liu; Wei Zhang; Xiaoyan Zhou
Journal:  Tumour Biol       Date:  2016-07-22

8.  Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma.

Authors:  Sani H Kizilbash; Shiv K Gupta; Kenneth Chang; Ryo Kawashima; Karen E Parrish; Brett L Carlson; Katrina K Bakken; Ann C Mladek; Mark A Schroeder; Paul A Decker; Gaspar J Kitange; Yuqiao Shen; Ying Feng; Andrew A Protter; William F Elmquist; Jann N Sarkaria
Journal:  Mol Cancer Ther       Date:  2017-09-25       Impact factor: 6.261

9.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

10.  The increasing urgency for standards in basic biologic research.

Authors:  Leonard P Freedman; James Inglese
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.